Minolira is an extended release tablet formulation of Minocycline, designed to release 25% of the dosage immediately and 75% in a sustained release timeframe. Available as tablets containing 105mg and 135mg of the mixture of release timed components of minocycline, Minolira tablets can also be split into 2 equal pieces allowing 4 different dose amounts. Your doctor will use your weight to determine how many half or full tablets you should take. The aim of this graduated approach is to keep the amount of minocycline in your blood at below antibiotic levels, but still off a benefit against your symptoms.

Recent Rosacea Blog Posts

Minolira for the treatment of rosacea

In 2017, the FDA approved the extended release formulation of minocycline, known as Minolira, for the treatment of severe acne vulgaris. The modified release formulation of doxycycline known as Oracea, was approved for the treatment of rosacea in 2006. As minocycline and doxycycline are related tetracyclines, Minolira may offer rosacea sufferers another rosacea treatment option, […]

Continue Reading



Subscribe to Rosacea News

Enter your email address to receive the latest news about rosacea in your inbox.